← Back to Search

Group 1 SCC/SSR for Cancer (SCH Trial)

N/A
Waitlist Available
Led By Kathleen Mooney, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Histological diagnosis of cancer
Life expectance of at least three months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

SCH Trial Summary

This trial will help determine what the most important and cost effective components are for a new approach to cancer chemotherapy symptom care. This could potentially help reduce symptoms for patients at home.

SCH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SCH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient reported symptom levels
Secondary outcome measures
Baseline Physical Activity
Health Care Utilization & Medical Encounters Interview
Overall Health functioning: physical, mental, and social
+2 more
Other outcome measures
Patient End of Study Telephone Interview

SCH Trial Design

5Treatment groups
Active Control
Group I: Group 1 SCC/SSRActive Control2 Interventions
This arm includes self-care coaching (SCC) message during daily self-reported symptom severity report (SSR) calls to the automated system.
Group II: Group 2 NP/SSRActive Control2 Interventions
Alert reports are generated during the patient's daily symptom severity monitoring call if alert thresholds are reached. These alerts are monitored and follow-up care is given by a nurse practitioner.
Group III: Group 3 NP/DSS/SSRActive Control3 Interventions
Alert reports are generated during the patient's daily symptom severity monitoring call if alert thresholds are reached. Nurse practitioner follow-up calls utilize the evidenced based SCH decision support system (DSS) when symptoms exceed alert thresholds
Group IV: Group 4 Full Intervention SSR/SCC/NP/DSSActive Control4 Interventions
Complete intervention with all components used in prior efficacy study (Symptom Severity Report (SSR)+Self Care Coaching (SCC) +Nurse Practitioner (NP) +Decision Support System (DSS))
Group V: Group 5 SSR/SCC/ATActive Control3 Interventions
Symptom severity reporting (SSR), automated self-care coaching (SCC) based on daily symptom reporting plus activity tracker (AT)

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,091 Previous Clinical Trials
1,731,678 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,626 Previous Clinical Trials
40,926,751 Total Patients Enrolled
Huntsman Cancer InstituteOTHER
12 Previous Clinical Trials
6,755 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~117 spots leftby Mar 2025